Awakn Life Sciences Signs Second Licensing Partnership Agreement and Expands Commercial Operations Into Canada Company News
Love Pharma Announces Strategic Acquisition of Doc Hygiene Pharmaceuticals Inc. Pharmaceutical Investing
Health Canada Grants MDMA Production and Distribution Amendment to Optimi Health Psychedelics Investing
Awakn Life Sciences Expands Commercial Operations into the U.S. - First Licensing Partnership Agreement with Revitalist Company News
 Revitalist Partners with Awakn Life Sciences as First Licensee in the United States to begin Redefining Treatment for Addiction, Recovery, and Relapse Prevention in the Psychedelic Space Company News
Lobe Sciences Enters into an Exclusive Agreement With iNGENu to Conduct Clinical Trials in Australia Pharmaceutical Investing
Optimi Health Unveils Canada's First Natural Therapeutic Psilocybin Product For Approved Patients Psychedelics Investing
Optimi Health To Launch Therapeutic Psilocybin Product In Partnership With Patient Advocate Thomas Hartle Psychedelics Investing
COMPASS Pathways plc announces second quarter 2022 financial results and business highlights Psychedelics Investing
Lobe Sciences Advances Governance and Capital Markets Expertise with Appointment of Mr. Nick Karakochuk to the Board of Directors
